Benjamin Procter

Senior Partner · Lexington, United States

Invests in AI

AI is one of the sectors on Benjamin Procter's investor profile, next to Biotech & Pharma, at Series B and late-stage venture. The record holds 2 deals, including Magenta Therapeutics and Synquiry Technologies.

Email Investor

Email Investor

Credits to line up before a Series B round

Benjamin Procter backs companies at Series B and late-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Magenta Therapeutics
  • Synquiry Technologies

Investment focus

Backs startups in
Artificial Intelligence, Biotech & Pharma
Rounds
Series B, Late-stage venture
Profile
Private equity investor
Deals on record
2
Based in
Lexington, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Benjamin Procter invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Benjamin Procter's investor profile, together with Biotech & Pharma. The stages on record are Series B and late-stage venture.
Which companies has Benjamin Procter backed?
The record lists 2 deals, including Magenta Therapeutics and Synquiry Technologies. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Benjamin Procter?
For a company raising a Series B round, AI Perks lists credits such as Deel (up to $5,000), Zendesk (up to $100,000), Attio (up to $5,000) and Oracle GTM (up to $5,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor